Autonomous or semi‑autonomous "autonomous vascular access" (AVA) platforms have the promise to standardize technique, accelerate placement by a wider range of providers, extend cannulation capability to austere settings, and reduce complication‑related morbidity.
The EVERDAC trial challenges routine placement, showing that in critically ill patients with shock, deferring arterial catheterization and using initial noninvasive monitoring with an automated brachial cuff was noninferior to early invasive monitoring for 28-day mortality.
Juan Pablo Arreola Nuñez· Critical Care & Emergenc...· 0 citations
The refinement of steerable micro catheters in tibial vessel intervention would expand current endovascular treatment and diagnostic capabilities, likely improving patient outcomes.
Yau C. Yun, L. Kraemer, J. Hallsten et al.· Journal of Clinical Medicine· 0 citations
This protocol provides a practical, evidence-based approach for ultrasound-guided peripheral VA-ECMO cannulation and focuses specifically on vascular access and cannulation rather than broader VA-ECMO management.
X. Lei, Li-Hua Sun, Boming Xia et al.· Journal of Visualized Experi...· 0 citations
Routine early VA-ECMO in infarct-related CS has not demonstrated mortality benefit in randomized trials and is associated with increased complications; therefore, VA-ECMO should be reserved for selected phenotypes, including refractory shock with severe hypoxemia, profound biventricular failure, or circulatory collapse...
Alexander M. Bernhardt, C. Volgmann, L. Bax et al.· European surgical research....· 0 citations
The patient had a history of implantable cardioverter-defibrillator insertion, who presented for chronic pulmonary embolism, and was later diagnosed with an implantable cardioverter-defibrillator infection, complicated with septic pulmonary embolization.
Jeffrey C. Y. Lee, R. Gallen, Nickpreet Singh et al.· JACC Case Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.